UJ4-15965-86410
4 vaccinations
3 coded responses
37 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 553 / MN
- Registered
- 2021-04-26
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
9LC-12518-20242
Child or adolescent in my care · Female · 2021-11-05
2TP-26317-24475
Child or adolescent in my care · Male · 2023-03-20
Timeline
-
2021-04-01
Dose 1 — Moderna
-
2021-04-26
Registered in v-safe
- 2021-04-26
-
2021-04-29
Dose 2 — Moderna
- 2021-04-29
-
2021-04-30
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to workAdult check-in
-
2021-05-01
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fever · Joint pains, Muscle or body achesAdult check-in
- 2021-05-02
- 2021-05-03
- 2021-05-04
- 2021-05-05
- 2021-05-06
-
2021-05-13
Survey response — day 14, dose 2MedDRA: Arthralgia, Myalgia — Feeling: GoodFree text: Minor, random, periodic joint and muscle aches for a period of 2 daysMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-20
- 2021-05-27
- 2021-06-03
- 2021-06-10
- 2021-07-29
- 2021-10-28
-
2021-11-05
Dose 3 — Moderna
- 2021-11-05
-
2021-11-06
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-11-07
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Swelling · HeadacheAdult check-in
- 2021-11-08
- 2021-11-09
- 2021-11-11
- 2021-11-12
- 2021-11-19
- 2021-11-26
- 2021-12-03
- 2021-12-12
- 2021-12-17
- 2022-02-04
- 2022-05-06
-
2022-09-17
Dose 4 — Pfizer-BioNTech
- 2022-10-04
- 2022-10-08
- 2022-10-17
-
2022-10-22
Survey response — day 35, dose 4MedDRA: Cough, Nasal congestion, Rhinorrhoea, Sneezing — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Stuffy runny nose, sneezing, coughMedDRA releases: 2024-11 · check-in free text available
- 2022-10-29
-
2022-12-19
Survey response — 3 months, dose 4MedDRA: SARS-CoV-2 test positive — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Positive COVID-19 antigen testMedDRA releases: 2024-11 · check-in free text available
- 2023-03-18
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-01 | Moderna | |
| 2 | 2021-04-29 | Moderna | |
| 3 | 2021-11-05 | Moderna | No |
| 4 | 2022-09-17 | Pfizer-BioNTech | No |
Free text
Release 8 — day 14, dose 2
Symptoms: Minor, random, periodic joint and muscle aches for a period of 2 days
Release 12 — day 35, dose 4
Symptoms: Stuffy runny nose, sneezing, cough
Release 12 — 3 months, dose 4
Symptoms: Positive COVID-19 antigen test
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Arthralgia | ✓ | ✓ | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Myalgia | ✓ | ✓ | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release